Assignee
ELUCID BIOIMAGING INC
US·38 granted patents·20 pending applications·1,046 citations·filing 2016–2025
Top patents by PatentIndex Score
58 records- 0199US12236595B2Characterizing permeability, neovascularization, necrosis, collagen breakdown, or inflammationELUCID BIOIMAGING INC·Filed 2023·Granted Feb 25, 2025·9 cites·12 claims
- 0299US12229957B2Systems and methods for diagnostics for management of cardiovascular disease patientsELUCID BIOIMAGING INC·Filed 2023·Granted Feb 18, 2025·9 cites·9 claims
- 0399US12159406B2Determining biological properties of atherosclerotic plaque, coronary artery disease, or vasculopathyELUCID BIOIMAGING INC·Filed 2023·Granted Dec 3, 2024·9 cites·12 claims
- 0499US12141975B2Myocardial ischemia predictionELUCID BIOIMAGING INC·Filed 2024·Granted Nov 12, 2024·9 cites·14 claims
- 0599US12136214B2Non-invasive imaging to inform patient careELUCID BIOIMAGING INC·Filed 2024·Granted Nov 5, 2024·13 cites·15 claims
- 0699US12131471B2Longitudinal change measures for optimizing patient careELUCID BIOIMAGING INC·Filed 2023·Granted Oct 29, 2024·13 cites·15 claims
- 0799US12131472B2Non-invasive imaging to determine health and diseaseELUCID BIOIMAGING INC·Filed 2023·Granted Oct 29, 2024·15 cites·15 claims
- 0899US12106477B2Segmenting permeability, neovascularization, necrosis, collagen breakdown, or inflammation to characterize atherosclerotic plaque, coronary artery disease, or vasculopathyELUCID BIOIMAGING INC·Filed 2023·Granted Oct 1, 2024·13 cites·12 claims
- 0999US12073561B2Multiscale modeling to determine molecular profiles from radiologyELUCID BIOIMAGING INC·Filed 2023·Granted Aug 27, 2024·16 cites·20 claims
- 1099US12045983B2Functional measures of stenosis significanceELUCID BIOIMAGING INC·Filed 2023·Granted Jul 23, 2024·17 cites·22 claims
- 1199US12039765B2Systems and methods for optimizing analysis of CT angiographyELUCID BIOIMAGING INC·Filed 2023·Granted Jul 16, 2024·17 cites·20 claims
- 1299US12026868B2Quantitative imaging for detecting histopathologically defined plaque erosion non-invasivelyELUCID BIOIMAGING INC·Filed 2021·Granted Jul 2, 2024·17 cites·23 claims
- 1399US12008751B2Quantitative imaging for detecting histopathologically defined plaque fissure non-invasivelyELUCID BIOIMAGING INC·Filed 2021·Granted Jun 11, 2024·15 cites·23 claims
- 1499US11696735B2Quantitative imaging for instantaneous wave-free ratioELUCID BIOIMAGING INC·Filed 2021·Granted Jul 11, 2023·22 cites·25 claims
- 1599US11676359B2Non-invasive quantitative imaging biomarkers of atherosclerotic plaque biologyELUCID BIOIMAGING INC·Filed 2021·Granted Jun 13, 2023·28 cites·20 claims
- 1699US11607179B2Non-invasive risk stratification for atherosclerosisELUCID BIOIMAGING INC·Filed 2021·Granted Mar 21, 2023·19 cites·21 claims
- 1799US11508063B2Non-invasive measurement of fibrous cap thicknessELUCID BIOIMAGING INC·Filed 2020·Granted Nov 22, 2022·42 cites·8 claims
- 1899US11120312B2Quantitative imaging for cancer subtypeELUCID BIOIMAGING INC·Filed 2018·Granted Sep 14, 2021·70 cites·23 claims
- 1999US11094058B2Systems and method for computer-aided phenotyping (CAP) using radiologic imagesELUCID BIOIMAGING INC·Filed 2018·Granted Aug 17, 2021·72 cites·19 claims
- 2099US11087460B2Methods and systems for training and validating quantitative imaging biomarkersELUCID BIOIMAGING INC·Filed 2018·Granted Aug 10, 2021·74 cites·29 claims
- 2199US11087459B2Quantitative imaging for fractional flow reserve (FFR)ELUCID BIOIMAGING INC·Filed 2018·Granted Aug 10, 2021·65 cites·22 claims
- 2298US12154321B2Structured representations for interpretable machine learning applications in medical imagingELUCID BIOIMAGING INC·Filed 2023·Granted Nov 26, 2024·8 cites·28 claims
- 2398US12125572B2Determining likely response to anti-inflammatory and pro-resolving therapies for cardiovascular disease non-invasivelyELUCID BIOIMAGING INC·Filed 2023·Granted Oct 22, 2024·15 cites·38 claims
- 2498US11887734B2Systems and methods for clinical decision support for lipid-lowering therapies for cardiovascular diseaseELUCID BIOIMAGING INC·Filed 2022·Granted Jan 30, 2024·20 cites·24 claims
- 2598US11887701B2Non-invasive determination of likely response to anti-inflammatory therapies for cardiovascular diseaseELUCID BIOIMAGING INC·Filed 2022·Granted Jan 30, 2024·19 cites·30 claims
- 2698US11887713B2Non-invasive determination of likely response to anti-diabetic therapies for cardiovascular diseaseELUCID BIOIMAGING INC·Filed 2022·Granted Jan 30, 2024·18 cites·24 claims
- 2798US11869186B2Non-invasive determination of likely response to combination therapies for cardiovascular diseaseELUCID BIOIMAGING INC·Filed 2022·Granted Jan 9, 2024·18 cites·23 claims
- 2898US11113812B2Quantitative imaging for detecting vulnerable plaqueELUCID BIOIMAGING INC·Filed 2018·Granted Sep 7, 2021·65 cites·23 claims
- 2998US11071501B2Quantitative imaging for determining time to adverse event (TTE)ELUCID BIOIMAGING INC·Filed 2018·Granted Jul 27, 2021·61 cites·20 claims
- 3098US10740880B2Systems and methods for analyzing pathologies utilizing quantitative imagingELUCID BIOIMAGING INC·Filed 2018·Granted Aug 11, 2020·50 cites·49 claims
- 3197US12125571B2Determining likely response to glycemic treatment for cardiovascular disease non-invasivelyELUCID BIOIMAGING INC·Filed 2023·Granted Oct 22, 2024·13 cites·32 claims
- 3297US12118694B2Progressive exploitation of multi-energy and photon counting modalitiesELUCID BIOIMAGING INC·Filed 2023·Granted Oct 15, 2024·13 cites·12 claims
- 3397US12100149B2Determining likely response to combination therapies for cardiovascular disease non-invasivelyELUCID BIOIMAGING INC·Filed 2023·Granted Sep 24, 2024·13 cites·28 claims
- 3497US11715187B2Extended tissue types for increased granularity in cardiovascular disease phenotypingELUCID BIOIMAGING INC·Filed 2022·Granted Aug 1, 2023·17 cites·12 claims
- 3597US11657486B2Systems and methods for improving soft tissue contrast, multiscale modeling and spectral CTELUCID BIOIMAGING INC·Filed 2022·Granted May 23, 2023·19 cites·6 claims
- 3697US11593926B2Systems and methods for improving soft tissue contrast, multiscale modeling and spectral CTELUCID BIOIMAGING INC·Filed 2021·Granted Feb 28, 2023·19 cites·20 claims
- 3795US11257584B2Quantitative medical imaging reportingELUCID BIOIMAGING INC·Filed 2018·Granted Feb 22, 2022·57 cites·23 claims
- 3893US10755810B2Methods and systems for representing, storing, and accessing computable medical imaging-derived quantitiesELUCID BIOIMAGING INC·Filed 2016·Granted Aug 25, 2020·57 cites·48 claims
- 3990US2025061572A1Systems and methods for diagnostics for management of cardiovascular disease patientsELUCID BIOIMAGING INC·Filed 2024·Application pending·0 cites
- 4085US2024062901A1Systems and methods to aid clinical decision support for glycemic treatment for cardiovascular diseaseELUCID BIOIMAGING INC·Filed 2023·Application pending·0 cites
- 4185US2023420130A1Clinical decision support to aid dyslipidemia therapies for cardiovascular diseaseELUCID BIOIMAGING INC·Filed 2023·Application pending·0 cites
- 4285US2024087742A1Systems and methods to aid clinical decision support for combination therapies for cardiovascular diseaseELUCID BIOIMAGING INC·Filed 2023·Application pending·0 cites
- 4385US2024006066A1Clinical decision support to aid interventional vs medical therapies for cardiovascular diseaseELUCID BIOIMAGING INC·Filed 2023·Application pending·0 cites
- 4485US2023420131A1Clinical decision support to aid watchful waiting of cardiovascular diseaseELUCID BIOIMAGING INC·Filed 2023·Application pending·0 cites
- 4585US2024021306A1Systems and methods to aid clinical decision support for anti-inflammatory and pro-resolving therapies for cardiovascular diseaseELUCID BIOIMAGING INC·Filed 2023·Application pending·0 cites
- 4684US2024394841A1Progressive exploitation of multi-energy and photon counting modalitiesELUCID BIOIMAGING INC·Filed 2024·Application pending·0 cites
- 4783US2024371000A1Combined assessment of morphological and perivascular disease markersELUCID BIOIMAGING INC·Filed 2024·Application pending·0 cites
- 4883US2023245775A1In silico systems biology model of lipid-lowering therapies for cardiovascular diseaseELUCID BIOIMAGING INC·Filed 2023·Application pending·0 cites
- 4982US2023420144A1Screening potential subjects for enrollment in dyslipidemia therapy clinical trialsELUCID BIOIMAGING INC·Filed 2023·Application pending·0 cites
- 5082US2023420143A1Screening candidate dyslipidemia agentsELUCID BIOIMAGING INC·Filed 2023·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ELUCID BIOIMAGING INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →